drugset
drugset / Trial / NCT04683627

A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee

NCT04683627 ↗

Phase 3 Completed 370 enrolled Noven Pharmaceuticals, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

A 12-week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 study to Evaluate the Efficacy and Safety of HP-5000 in Subjects with Osteoarthritis (OA) Pain of the Knee

Timeline

Start
2020-12-29
Primary completion
2022-07-18
Completion
2022-07-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified — Topical

Indications

osteoarthritis, knee